Faslodex is manufactured in the UK and shipped from our pharmacy in India by courier with cold chain packaging.
Information about Faslodex (Fulvestrant)
Faslodex is an injectable medication primarily used in the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. It acts as an estrogen receptor antagonist, inhibiting the growth of estrogen-dependent tumors.
Product Highlights
- Specifically for postmenopausal women with hormone receptor-positive breast cancer who have progressed on anti-estrogen therapy.
Key Ingredient
Key Benefits
- Shown to reduce tumor size and progression in hormone receptor-positive breast cancer.
- Works differently from other hormonal therapies, making it suitable for patients who have developed resistance to other treatments.
- Clinical studies indicate improved progression-free survival compared to certain alternatives.
Direction of Use
- Faslodex is administered by a healthcare professional via intramuscular injection, typically in the buttock.
- Patients should be monitored for any immediate reactions following administration.
Safety Concerns
- Injection site reactions, nausea, fatigue, and hot flashes.
- Risk of liver toxicity and blood clots; patients may require liver function monitoring.
- Potential for menopausal symptoms due to hormonal changes.
Avoid Faslodex (Fulvestrant) If
- You have a known hypersensitivity to fulvestrant or any component of the formulation.
- You are pregnant or intend to become pregnant.
- You have severe liver impairment or active liver disease.
This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.
